Search Results - avindra+nath

3 Results

Sort By:

Angiotensin Receptor as a Therapeutic Target for Autism Disorder

C11584: Diagnosis and of Autism based on Specific Receptor SiteNovelty: This invention is a new method to test pregnant mothers for an increased risk of having autistic children. The identification of this receptor-specific antibody suggests that specific inhibitors, antibodies, or other agents can be used as a therapy for autism.Value Proposition:...

Published: 7/4/2024 | Inventor(s): Tongguang Wang, Christina Morris-Berry, Harvey Singer, Avindra Nath

Keywords(s): Autism, Biomarker, CNS and Neurological Disorders, Disease Indication, Mechanism of Action Biomarker, Therapeutic Matter, Therapeutics

Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Psychiatry > Autism, Technology Classifications > Diagnostics > Biomarkers, Technology Classifications > Therapeutic Modalities > Targets, Technology Classifications > Diagnostics, Clinical and Disease Specializations > Psychiatry, Technology Classifications > Therapeutic Modalities

Role of Limonoid Compounds As Neuroprotective Agents

Invention novelty: A series of compounds from the limonoid family that can be used in protecting neurons from different types of toxicity. Unmet Need: Neurodegenerative diseases are characterized by extensive deterioration of neurons or glia. Because these cells are not easily regenerated, there is an emerging unmet medical need for a therapeutic...

Published: 7/4/2024 | Inventor(s): Norman Haughey, Avindra Nath, Joseph Steiner

Keywords(s): CNS and Neurological Disorders, Disease Indication, Multiple CNS Indications, Natural compounds, Neurodegeneration, Neurodegenerative Diseases, Non-novel, Predicted Novelty, Small Molecules, Therapeutic Matter, Therapeutic Substance, Therapeutics

Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Neurology, Clinical and Disease Specializations > Neurology > Neurodegeneration, Technology Classifications > Therapeutic Modalities > Small Molecules, Technology Classifications > Therapeutic Modalities

Diagnostic and Prognostic Markers and Treatment Strategies for Multiple Sclerosis

C04371: Novel Diagnostic and Prognostic Multiple Sclerosis Protein BiomarkerNovelty: A novel diagnostic and prognostic protein biomarker in Cerebral Spinal Fluid that is 100% specific for Multiple Sclerosis when compared to other neurologic disorders.Value Proposition: Current Multiple Sclerosis diagnosis is produced and confirmed strictly by clinical...

Published: 7/4/2024 | Inventor(s): Caroline Anderson, David Irani, Robert Cotter, Norman Haughey, Joseph Steiner, Avindra Nath

Keywords(s): Biomarker, Chronic Inflammatory Diseases, Clinical Diagnostics, CNS and Neurological Disorders, Diagnostic Biomarker, Disease Indication, In Vitro Diagnostics, Multiple Sclerosis, Multiple Sclerosis (MS), Neurodegeneration, Prognostic Biomarker